Treace Medical Earnings Estimate

TMCI Stock  USD 8.56  0.28  3.38%   
By analyzing Treace Medical's earnings estimates, investors can diagnose different trends across Treace Medical's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Treace Medical Concepts is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Treace Medical is projected to generate -0.23255 in earnings per share on the 31st of December 2024. Treace Medical earnings estimates module stress-tests analyst consensus about projected Treace Medical Concepts EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Treace Medical, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Treace Medical's earnings estimates, investors can diagnose different trends across Treace Medical's analyst sentiment over time as well as compare current estimates against different timeframes. The current Gross Profit is estimated to decrease to about 92.3 M. The current Pretax Profit Margin is estimated to decrease to -0.28
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Treace Medical Concepts. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Treace Medical Earnings per Share Projection vs Actual

About Treace Medical Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Treace Medical earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Treace Medical estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Treace Medical fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-134.2 M-127.5 M
Retained Earnings Total Equity-76.2 M-80.1 M
Earnings Yield(0.06)(0.06)
Price Earnings Ratio(15.67)(16.45)
Price Earnings To Growth Ratio 2.69  2.83 

Currently Active Assets on Macroaxis

When determining whether Treace Medical Concepts offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Treace Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Treace Medical Concepts Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Treace Medical Concepts Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Treace Medical Concepts. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Treace Medical. If investors know Treace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Treace Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.99)
Revenue Per Share
3.274
Quarterly Revenue Growth
0.106
Return On Assets
(0.17)
Return On Equity
(0.51)
The market value of Treace Medical Concepts is measured differently than its book value, which is the value of Treace that is recorded on the company's balance sheet. Investors also form their own opinion of Treace Medical's value that differs from its market value or its book value, called intrinsic value, which is Treace Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Treace Medical's market value can be influenced by many factors that don't directly affect Treace Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Treace Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Treace Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Treace Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.